Cbdmd maintains commitment to advocating for fda regulation despite recent news

Leading cbd company comments on fda declining to regulate the industry and calling on congress to create new rulescharlotte, north carolina--(newsfile corp. - january 26, 2023) - cbdmd, inc. (nyse american: ycbd) (nyse american: ycbdpa), one of the nation's leading, highly trusted, and widely recognized cbd companies, announces their commitment to hold the fda accountable for years of oversight regarding the establishment of safe regulatory frameworks appropriate for cannabinoids.
YCBD Ratings Summary
YCBD Quant Ranking